| BeiGene Switzerland GmbH - Tevimbra, 100 mg / 10 ml Konzentrat zur Herstellung einer Infusionslösung | | 68960 | | 01 | | Tevimbra, 100 mg / 10 ml Konzentrat zur Herstellung einer Infusionslösung | | | | L01FF09 | | | | 11.04.2024 | | |
| | Composition | | tislelizumabum 100 mg, natrii citras dihydricus, acidum citricum monohydricum, histidini hydrochloridum monohydricum, histidinum, trehalosum dihydricum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 16 mg. | | Packungsbestandteile | | | | | | | Active Agent | Dose |
|---|
| Tislelizumabum | 100mg / 10ml |
| | BAG: Active Agent | Dose |
|---|
| Tislelizumabum | 100 mg |
| | | | Inactive agents |
|---|
| Citric Acid Monohydrate | | Histidin Hydrochloride Monohydrate | | Histidine | | Natrii Citras Dihydricus | | Polysorbatum 20 | | Trehalosum Dihydricum |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 1816.16 | 1991.60 | A | SL | No |
|
|
